(IPAR) Inter Parfums - Overview
Stock: Fragrances, Cosmetics, Perfumes, Skincare, Bodycare
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.93% |
| Yield on Cost 5y | 5.19% |
| Yield CAGR 5y | 33.75% |
| Payout Consistency | 94.3% |
| Payout Ratio | 73.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.6% |
| Relative Tail Risk | 0.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.81 |
| Alpha | -37.09 |
| Character TTM | |
|---|---|
| Beta | 0.763 |
| Beta Downside | 0.768 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.51% |
| CAGR/Max DD | -0.03 |
Description: IPAR Inter Parfums January 10, 2026
Interparfums, Inc. (NASDAQ: IPAR) designs, manufactures, markets and distributes a broad portfolio of licensed fragrance and cosmetic products for luxury and contemporary fashion brands, selling through department stores, specialty retailers, duty-free locations, wholesale distributors and e-commerce channels.
The business is split into two geographic segments – European-Based Operations and United States-Based Operations – and leverages licensing agreements with more than 30 well-known labels, including Coach, Jimmy Choo, Montblanc, Lacoste, and Roberto Cavalli.
In FY 2023 the company reported net revenue of approximately $215 million, a 7 % increase year-over-year, driven largely by a 12 % rise in e-commerce sales and stronger demand in the European market; adjusted EBITDA margin hovered around 14 % despite elevated raw-material costs.
Key industry drivers include a projected 5 % CAGR for the global luxury fragrance market through 2028, rising consumer spending in the premium personal-care segment, and a structural shift toward direct-to-consumer digital channels that can improve margin capture.
For a deeper, data-rich analysis of IPAR’s valuation metrics and scenario modeling, you may find ValueRay’s platform worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 164.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 3.71 > 1.0 |
| NWC/Revenue: 47.00% < 20% (prev 43.45%; Δ 3.54% < -1%) |
| CFO/TA 0.13 > 3% & CFO 206.3m > Net Income 164.5m |
| Net Debt (119.5m) to EBITDA (310.4m): 0.38 < 3 |
| Current Ratio: 3.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.1m) vs 12m ago -0.36% < -2% |
| Gross Margin: 64.41% > 18% (prev 0.64%; Δ 6378 % > 0.5%) |
| Asset Turnover: 96.14% > 50% (prev 95.88%; Δ 0.26% > 0%) |
| Interest Coverage Ratio: 36.38 > 6 (EBITDA TTM 310.4m / Interest Expense TTM 7.74m) |
Altman Z'' 7.73
| A: 0.44 (Total Current Assets 990.7m - Total Current Liabilities 302.8m) / Total Assets 1.56b |
| B: 0.53 (Retained Earnings 827.0m / Total Assets 1.56b) |
| C: 0.18 (EBIT TTM 281.4m / Avg Total Assets 1.52b) |
| D: 1.79 (Book Value of Equity 822.2m / Total Liabilities 460.2m) |
| Altman-Z'' Score: 7.73 = AAA |
Beneish M -3.01
| DSRI: 1.01 (Receivables 374.0m/359.7m, Revenue 1.46b/1.42b) |
| GMI: 0.99 (GM 64.41% / 63.89%) |
| AQI: 1.03 (AQ_t 0.23 / AQ_t-1 0.22) |
| SGI: 1.03 (Revenue 1.46b / 1.42b) |
| TATA: -0.03 (NI 164.5m - CFO 206.3m) / TA 1.56b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of IPAR shares?
Over the past week, the price has changed by +4.92%, over one month by +16.48%, over three months by +17.79% and over the past year by -24.11%.
Is IPAR a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IPAR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 107.4 | 4.9% |
| Analysts Target Price | 107.4 | 4.9% |
| ValueRay Target Price | 102.3 | -0.1% |
IPAR Fundamental Data Overview February 03, 2026
P/E Forward = 20.284
P/S = 2.1372
P/B = 3.5946
P/EG = 2.73
Revenue TTM = 1.46b USD
EBIT TTM = 281.4m USD
EBITDA TTM = 310.4m USD
Long Term Debt = 140.0m USD (from longTermDebt, last quarter)
Short Term Debt = 72.5m USD (from shortTermDebt, last quarter)
Debt = 229.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 119.5m USD (from netDebt column, last quarter)
Enterprise Value = 3.17b USD (3.13b + Debt 229.9m - CCE 187.9m)
Interest Coverage Ratio = 36.38 (Ebit TTM 281.4m / Interest Expense TTM 7.74m)
EV/FCF = 22.12x (Enterprise Value 3.17b / FCF TTM 143.3m)
FCF Yield = 4.52% (FCF TTM 143.3m / Enterprise Value 3.17b)
FCF Margin = 9.79% (FCF TTM 143.3m / Revenue TTM 1.46b)
Net Margin = 11.24% (Net Income TTM 164.5m / Revenue TTM 1.46b)
Gross Margin = 64.41% ((Revenue TTM 1.46b - Cost of Revenue TTM 520.9m) / Revenue TTM)
Gross Margin QoQ = 63.51% (prev 66.21%)
Tobins Q-Ratio = 2.03 (Enterprise Value 3.17b / Total Assets 1.56b)
Interest Expense / Debt = 1.00% (Interest Expense 2.31m / Debt 229.9m)
Taxrate = 22.58% (24.3m / 107.6m)
NOPAT = 217.9m (EBIT 281.4m * (1 - 22.58%))
Current Ratio = 3.27 (Total Current Assets 990.7m / Total Current Liabilities 302.8m)
Debt / Equity = 0.26 (Debt 229.9m / totalStockholderEquity, last quarter 870.9m)
Debt / EBITDA = 0.38 (Net Debt 119.5m / EBITDA 310.4m)
Debt / FCF = 0.83 (Net Debt 119.5m / FCF TTM 143.3m)
Total Stockholder Equity = 810.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.80% (Net Income 164.5m / Total Assets 1.56b)
RoE = 20.29% (Net Income TTM 164.5m / Total Stockholder Equity 810.9m)
RoCE = 29.60% (EBIT 281.4m / Capital Employed (Equity 810.9m + L.T.Debt 140.0m))
RoIC = 21.64% (NOPAT 217.9m / Invested Capital 1.01b)
WACC = 8.19% (E(3.13b)/V(3.36b) * Re(8.73%) + D(229.9m)/V(3.36b) * Rd(1.00%) * (1-Tc(0.23)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.06%
[DCF Debug] Terminal Value 80.66% ; FCFF base≈118.3m ; Y1≈145.9m ; Y5≈248.5m
Fair Price DCF = 122.5 (EV 4.05b - Net Debt 119.5m = Equity 3.93b / Shares 32.1m; r=8.19% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -6.64 | EPS CAGR: -47.01% | SUE: -4.0 | # QB: 0
Revenue Correlation: 84.92 | Revenue CAGR: 20.92% | SUE: -0.21 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.17 | Chg30d=+0.030 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=4.92 | Chg30d=+0.082 | Revisions Net=+2 | Growth EPS=-4.7% | Growth Revenue=+2.8%